At a virtual meeting convened by Yale SOM leadership expert Jeffrey Sonnenfeld in the wake of the attack on the Capitol, CEOs voiced worries and brainstormed ideas for how business can help strengthen democracy. 

Joe Biden and Kamala Harris will take on an array of monumental challenges, including controlling COVID-19, making progress on the climate crisis, and confronting racial injustice. We asked faculty members who specialize in these and other subjects what research-based counsel they would give to America’s new leaders.

In the final act of Donald Trump‘s presidency, Yale SOM's Jeffrey Sonnenfeld sees echoes of “monarchical” CEOs who purge truth-tellers and surround themselves with sycophants—and invariably make an involuntary exit from the C-suite.

In a hastily assembled call on November 6, corporate leaders agreed on the importance of smooth transition process and encouraged GOP leaders to endorse the integrity of the election.

In the face of pressure from President Donald Trump, nine major pharmaceutical companies have signed a pledge to complete testing before submitting vaccines for approval. Yale's Jeffrey Sonnenfeld and Dr. Albert Ko  write that the drugmakers’ caution may help provide badly needed confidence in the eventual vaccine.

If Joe Biden is elected this November, Kamala Harris would be the first woman and the first person of color to serve as vice president. We asked Prof. Oriane Georgeac, who studies perceptions of diversity, if Harris’s nomination heralds an acceleration of progress for women generally.

Some have defended cutbacks to the United States Postal Service, weeks ahead of the election, by citing the USPS’s financial struggles. But the postal service was created to provide a public service, writes Yale SOM’s Jeffrey Sonnenfeld, not to turn a profit.